Skip to main content
Log in

Molecular markers for predicting response to tamoxifen in breast cancer patients

  • Review
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Tamoxifen is one of the most effective treatments for breast cancer. Standard practice is to select patients who are likely to respond to this therapy through the evaluation of estrogen receptor (ER) and progesterone receptor (PR) in the primary tumor tissue. Over the past 25 yr that physicians have been using ER determination to guide tamoxifen use, numerous studies have demonstrated that this molecular marker is useful in predicting benefit from tamoxifen. ER has been analyzed for many years using ligand-binding assays. However, current practice involves the use of immunohistochemical-based assays to detect ERα Immunohistochemistry (IHC) has several advantages. For example, IHC evaluates tumor cell heterogeneity, can be used to study small samples, is less expensive, and allows direct correlation with multiple histopathological tumor features and other molecular markers. PR, an estrogen-responsive protein, can also be useful in predicting response to tamoxifen in specific clinical situations. In recent years, several other markers of tamoxifen response have been examined, including: pS2 (another estrogen-regulated protein), heat-shock proteins 27 and 70, bcl-2 protein, c-erbB-2 (HER-2/neu) oncoprotein, and mutated p53 tumor suppressor protein. In this article, we present an analysis of the data on these new molecular markers. Overall, from numerous studies, the data indicate that in addition to ERα bcl-2 is a potential candidate to help further improve our ability to predict response to tamoxifen. ER and bcl-2 are the most useful molecular markers to better identify breast cancer patients who will respond to tamoxifen and who will have prolonged survival.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Fitzpatrick, L. A. (1999). Mayo Clin. Proc. 74, 601–607.

    Article  PubMed  CAS  Google Scholar 

  2. Jordan, V. C. (1999). J. Clin. Oncol. 17, 2629–2631.

    PubMed  CAS  Google Scholar 

  3. Fisher, B., Dignam, J., Wolmark, N., et al. (1999). Lancet 353, 1993–2000.

    Article  PubMed  CAS  Google Scholar 

  4. Maddox, A.-M. (1989). Cancer Bull. 41, 52–55.

    Google Scholar 

  5. Johnston, S. R. D., Saccani-Jotti, G., Smith, I. E., et al. (1995). Cancer Res. 55, 3331–3338.

    PubMed  CAS  Google Scholar 

  6. Ruohola, J. K., Valve, E. M., Karkkainen, M. J., Joukov, V., Alitalo, K., and Harkonen, P. L. (1999). Mol. Cell. Endocrinol. 149, 29–40.

    Article  PubMed  CAS  Google Scholar 

  7. Maxwell, P. and van den Berg, H. W. (1999). Cancer Lett. 139, 121–127.

    Article  PubMed  CAS  Google Scholar 

  8. Langan-Fahey, S. M., Tormey, D. C., and Jordan, V. C. (1990). Eur. J. Cancer 26, 883–888.

    Article  PubMed  CAS  Google Scholar 

  9. Fabian, C., Sternson, L., El-Serafi, M., Cain, L., and Hearne, E. (1981). Cancer 48, 876–882.

    Article  PubMed  CAS  Google Scholar 

  10. Bratherton, D. G., Brown, C. H., Buchanan, R., et al. (1984). Br. J. Cancer 50, 199–205.

    PubMed  CAS  Google Scholar 

  11. Osborne, C. K., Wiebe, V. J., McGuire, W. L., Ciocca, D. R., and DeGregorio, M. W. (1992). J. Clin. Oncol. 10, 304–310.

    PubMed  CAS  Google Scholar 

  12. Sunderland, M. C. and Osborne, C. K. (1991). J. Clin. Oncol. 9, 1283–1297.

    PubMed  CAS  Google Scholar 

  13. Mosselman, S., Polman, J., and Dijkema, R. (1996). FEBS Lett. 392, 49–53.

    Article  PubMed  CAS  Google Scholar 

  14. Zou, A., Marschke, K. B., Arnold, K. E., et al. (1999). Mol. Endocrinol. 13, 418–430.

    Article  PubMed  CAS  Google Scholar 

  15. Jensen, E. V. and Jacobson, H. I. (1962). Recent Prog. Horm. Res. 18, 387–414.

    CAS  Google Scholar 

  16. McGuire, W. L. (1975). In: Methods in enzymology. O’Malley, B. W. and Hardman, J. G. (eds.). Academic: New York.

    Google Scholar 

  17. Early Breast Cancer Trialists’ Collaborative Group. (1998). Lancet 351, 1451–1467.

    Article  Google Scholar 

  18. Coradini, D., Oriana, S., Biganzoli, E., et al. (1999). Int. J. Biol. Markers 14, 60–67.

    PubMed  CAS  Google Scholar 

  19. Gotteland, M., May, E., May-Levin, F., Contesso, G., Delarue, J.-C., and Mourisse, H. (1994). Cancer 74, 864–871.

    Article  PubMed  CAS  Google Scholar 

  20. Fuqua, S. A. W., Chamness, G. C., and McGuire, W. L. (1993). J. Biol. Chem. 51, 1235–1239.

    Google Scholar 

  21. Levin, E., Actis, A. M., Caruso, S., et al. (1997). Int. J. Cancer 73, 486–491.

    Article  PubMed  CAS  Google Scholar 

  22. Dehdashti, F., Flanagan, F. L., Mortimer, J. E., Katzenellenbogen, J. A., Welch, M. J., and Siegel, B. A. (1999). Eur. J. Nucl. Med. 26, 51–56.

    Article  PubMed  CAS  Google Scholar 

  23. Takimoto, G. S., Graham, J. D., Jackson, T. A., et al. (1999). J. Steroid Biochem. Mol. Biol. 69, 45–50.

    Article  PubMed  CAS  Google Scholar 

  24. Holmes, F. A., Fritsche, H. A., Loewy, J. W., et al. (1990). J. Clin. Oncol. 8, 1025–1035.

    PubMed  CAS  Google Scholar 

  25. Allred, D. C., Bustamante, M. A., Daniel, C. O., Gaskill, H. V., and Cruz, A. B. Jr. (1990). Arch. Surg. 125, 107–113.

    PubMed  CAS  Google Scholar 

  26. Elledge, R. M., Green, S., Pugh, R., et al. (2000) Int. J. Cancer (Predictive Oncol) 89, 111–117.

    Article  CAS  Google Scholar 

  27. Shi, S.-R., Imam, S. A., Young, L., Cote, R. J., and Taylor, C. R. (1995). J. Histochem. Cytochem. 43, 193–201.

    PubMed  CAS  Google Scholar 

  28. Fanelli, M. A., Vargas-Roig, L. M., Gago, F. E., Tello, O., Lucero De Angelis, R., and Ciocca, D. R. (1996). Breast Cancer Res. Treat. 37, 217–228.

    Article  PubMed  CAS  Google Scholar 

  29. Pertschuk, L. P., Feldman, J. G., Kim, Y.-D., et al. (1996). Cancer 77, 2514–2519.

    Article  PubMed  CAS  Google Scholar 

  30. Harvey, J. M., Clark, G. M., Osborne, C. K., and Allred, D. C. (1999). J. Clin. Oncol. 17, 1474–1481.

    PubMed  CAS  Google Scholar 

  31. Allred, D. C., Harvey, J. M., Berardo, M, and Clark, G. M. (1998). Modern Pathol. 11, 155–168.

    CAS  Google Scholar 

  32. Badwe, R. A., Gregory, W. M., Chaudary, M. A., et al. (1991). Lancet 337, 1261–1264.

    Article  PubMed  CAS  Google Scholar 

  33. Elledge, R. M., Ciocca, D. R., Langone, G., and McGuire, W. L. (1993). Cancer 71, 2499–2506.

    Article  PubMed  CAS  Google Scholar 

  34. Encarnación, C. A., Ciocca, D. R., McGuire, W. L., Clark, G. M., Fuqua, S. A. W., and Osborne, C. K. (1993). Breast Cancer Res. Treat. 26, 237–246.

    Article  PubMed  Google Scholar 

  35. Makris, A., Powles, T. J., Allred, D. C., et al. (1999). Breast Cancer Res. Treat. 53, 51–59.

    Article  PubMed  CAS  Google Scholar 

  36. Brankovicmagic, M. V., Nikolicvukosavljevic, D. B., Neskovickonstantinovic, Z. B., Kanjer, K. S., and Spuzic, I. V. (1992). Acta Oncol. 31, 629–633.

    Article  CAS  Google Scholar 

  37. Gago, F. E., Tello, O. M., Diblasi, A. M., and Ciocca, D. R. (1998). J. Steroid Biochem. Mol. Biol. 67, 431–437.

    Article  PubMed  CAS  Google Scholar 

  38. Toft, D. O. and O’Malley, B. W. (1972). Endocrinology 90, 1041–1045.

    Article  PubMed  CAS  Google Scholar 

  39. Horwitz, K. B., McGuire, W. L., Pearson, O. H., and Selagoff, A. (1975). Science 189, 726–727.

    Article  PubMed  CAS  Google Scholar 

  40. McGuire, W. L. and Clark, G. M. (1983) Semin. Oncol. 10, 2–6.

    PubMed  CAS  Google Scholar 

  41. Ciocca, D. R. and Vargas-Roig, L. M. (1995). Endocr. Rev. 16, 35–62.

    Article  PubMed  CAS  Google Scholar 

  42. Kiang, D. T. and Kollander, R. (1987). J. Clin. Oncol. 5, 662–666.

    PubMed  CAS  Google Scholar 

  43. Horwitz, K. B., Koseki, Y., and McGuire, W. L. (1978). Endocrinology 103, 1742–1751.

    PubMed  CAS  Google Scholar 

  44. Howell, A., Harland, R. N. L., Barnes, D. M., et al. (1987). Cancer Res. 47, 300–304.

    PubMed  CAS  Google Scholar 

  45. Montoya, F., Barbazan, M. J., Schneider, J., Matorras, R., and Rodríguez Escudero, F. J. (1992). Oncology 49, 422–425.

    Article  PubMed  CAS  Google Scholar 

  46. Chang, J., Powles, T. J., Allred, D. C., et al. (1999). J. Clin. Oncol. 17, 3058–3063.

    PubMed  CAS  Google Scholar 

  47. Rio, M.-C. and Chambon, P. (1990). Cancer Cells 2, 269–274.

    PubMed  CAS  Google Scholar 

  48. Foekens, J. A., Rio, M.-C., Seguin, P., et al. (1990). Cancer Res. 50, 3832–3837.

    PubMed  CAS  Google Scholar 

  49. Schwartz, L. H., Koerner, F. C., Edgerton, S. M., et al. (1991). Cancer Res. 51, 624–628.

    PubMed  CAS  Google Scholar 

  50. Ciocca, D. R., Green, S., Elledge, R. M., et al. (1998). Clin. Cancer Res. 5, 1263–1266.

    Google Scholar 

  51. Chen, S., Prapapanich, V., Rimerman, R. A., Honor, B., and Smith, D. F. (1996). Mol. Endocrinol. 10, 682–693.

    Article  PubMed  CAS  Google Scholar 

  52. Ciocca, D. R., Oesterreich, S., Chamness, G. C., McGuire, W. L., and Fuqua, S. A. W. (1993). J. Natl. Cancer Inst. 85, 1558–1570.

    Article  PubMed  CAS  Google Scholar 

  53. Vargas-Roig, L. M., Gago, F. E., Tello, O., Aznar, J. C., and Ciocca, D. R. (1998). Int. J. Cancer (Pred. Oncol.). 79, 468–475.

    Article  CAS  Google Scholar 

  54. Korsmeyer, S. J. (1999). Cancer Res. 59(Suppl.), 1693s-1700s.

    PubMed  CAS  Google Scholar 

  55. Zhang, G.-J., Kimijima, I., Tsuchiya, A., and Abe, R. (1998). Oncol. Rep. 5, 1211–1216.

    PubMed  CAS  Google Scholar 

  56. Cory, S., Vaux, D. L., Strasser, A., Harris, A. W., and Adams, J. M. (1999). Cancer Res. 59(Suppl.), 1685s-1692s.

    PubMed  CAS  Google Scholar 

  57. Gee, J. M., Robertson, J. F., Ellis, I. O., et al. (1994). Int. J. Cancer 59, 619–628.

    Article  PubMed  CAS  Google Scholar 

  58. Gasparini, G., Barbareschi, M., Doglioni, C., et al. (1995). Clin. Cancer Res. 1, 189–198.

    PubMed  CAS  Google Scholar 

  59. Keen, J. C., Dixon, J. M., Miller, E. P., et al. (1997). Breast Cancer Res. Treat. 44, 123–133.

    Article  PubMed  CAS  Google Scholar 

  60. Elledge, R. M., Green, S., Howes, L., et al. (1997). J. Clin. Oncol. 15, 1916–1922.

    PubMed  CAS  Google Scholar 

  61. Daidone, M. G., Luisi, A., Martelli, G., et al. (2000). Br. J. Cancer 82, 270–277.

    Article  PubMed  CAS  Google Scholar 

  62. Leung, L. K. and Wang, T. T. (1999). Br. J. Cancer 81, 387–392.

    Article  PubMed  CAS  Google Scholar 

  63. Zhang, G. J., Kimijima, I., Onda, M., et al. (1999). Clin. Cancer Res. 5, 2971–3007.

    PubMed  CAS  Google Scholar 

  64. Tzahar, E. and Yarden, Y. (1998). Biochim. Biophys. Acta 1377, M25-M37.

    PubMed  CAS  Google Scholar 

  65. Vargas-Roig, L. M., Gago, F. E., Tello, O., Martín de Civetta, M. T., and Ciocca, D. R. (1999). Int. J. Cancer (Pred. Oncol.). 84, 129–134.

    Article  CAS  Google Scholar 

  66. Hengstler, J. G., Lange, J., Kett, A., et al. (1999). Cancer Res. 59, 3206–3214.

    PubMed  CAS  Google Scholar 

  67. Cobleigh, M. A., Vogel, C. L., Tripathy, D., et al. (1999). J. Clin. Oncol. 17, 2639–2648.

    PubMed  CAS  Google Scholar 

  68. Read, L. D., Keith, D. Jr., Slamon, D. J., and Katzenellenbogen, B. S. (1990). Cancer Res. 50, 3947–3951.

    PubMed  CAS  Google Scholar 

  69. Dati, C., Antoniotti, S., Taverna, D., Perroteau, I., and De Bortoli, M. (1990). Oncogene 5, 1001–1006.

    PubMed  CAS  Google Scholar 

  70. Mizukami, Y., Tajiri, K., Nonomura, A., et al. Anticancer Res. 11, 1333–1338.

  71. Johnston, S. R., McLennan, K. A., Salter, J., et al. (1993). Breast 2, 93–99.

    Article  Google Scholar 

  72. Press, M. F., Cordon-Cardo, C., and Slamon, D. J. (1990). Oncogene 5, 953–962.

    PubMed  CAS  Google Scholar 

  73. Roux-Dosseto, M., Romain, S., Dussault, N., and Martin, P. M. (1989). Biomed. Pharmacother. 43, 641–649.

    Article  PubMed  CAS  Google Scholar 

  74. Ciocca, D. R., Fujimura, F. K., Tandon, A. K., et al. (1992). J. Natl. Cancer Inst. 84, 1279–1282.

    Article  PubMed  CAS  Google Scholar 

  75. Benz, C. C., Scott, G. K., Sarup, J. C., et al. (1992). Breast Cancer Res. Treat. 24, 85–95.

    Article  PubMed  CAS  Google Scholar 

  76. Pietras, R. J., Arboleda, J., Reese, D. M., et al. (1995). Oncogene 10, 2435–2445.

    PubMed  CAS  Google Scholar 

  77. Wright, C., Nicholson, S., Angus, B., et al. (1992). Br. J. Cancer 65, 118–121.

    PubMed  CAS  Google Scholar 

  78. Kumar, R., Mandal, M., Lipton, A., Harvey, H., and Thompson, C. B. (1996). Clin. Cancer Res. 2, 1215–1219.

    PubMed  CAS  Google Scholar 

  79. Borg, A., Baldetorp, B., Ferno, M., Killander, D., Olsson, H., Ryden, S., and Sigurdsson, H. (1994). Cancer Lett. 8, 137–144.

    Article  Google Scholar 

  80. Archer, S. G., Eliopoulous, A., Spandidos, D., et al. (1995). Br. J. Cancer 72, 1259–1266.

    PubMed  CAS  Google Scholar 

  81. Berns, M. J. J., Foekens, J. A., van Staveren, I. L., van Putten, W. L. J., de Koning, H. Y. W. C. M., and Klijn, J. G. M. (1995). Gene 159, 11–18.

    Article  PubMed  CAS  Google Scholar 

  82. Leitzel, K., Teramoto, Y., Konrad, K., et al. (1995). J. Clin. Oncol. 13, 1129–1135.

    PubMed  CAS  Google Scholar 

  83. Carlomagno, C., Perrone, F., Gallo, C., et al. (1996). J. Clin. Oncol. 14, 2702–2708.

    PubMed  CAS  Google Scholar 

  84. Yamauchi, H., O’Neill, A., Gelman, R., et al. (1997). J. Clin. Oncol. 15, 2518–2525.

    PubMed  CAS  Google Scholar 

  85. Newby, J. C., Johnson, S. R., Smith, I. E., and Dowsett, M. (1997). Clin. Cancer Res. 3, 1643–1651.

    PubMed  CAS  Google Scholar 

  86. Elledge, R. M., Green, S., Ciocca, D., et al. (1998). Clin. Cancer Res. 4, 7–12.

    PubMed  CAS  Google Scholar 

  87. Houston, S. J., Plunkett, T. A., Barnes, D. M., Smith, P., Rubens, R. D., and Miles, D. W. (1999). Br. J. Cancer 79, 1220–1226.

    Article  PubMed  CAS  Google Scholar 

  88. Muss, H., Berry, D., Thor, A., et al. (1999). Proc. ASCO 18, 68a (abstract 256).

  89. Stonelake, P. S., Baker, P. G., Gillespie, W. M., et al. (1994). Eur. J. Cancer 30A, 5–11.

    Article  PubMed  CAS  Google Scholar 

  90. Ferno, M., Baldetorp, B., Bendahl, P. O., et al. (1995). Breast Cancer Res. Treat. 36, 23–34.

    Article  PubMed  CAS  Google Scholar 

  91. Thomssen, C., Schmitt, M., Goretzki, L., et al. (1995). Clin. Cancer Res. 1, 741–746.

    PubMed  CAS  Google Scholar 

  92. Gasparini, G., Fox, S. B., Verderio, P., et al. (1996). Clin. Cancer Res. 2, 1191–1198.

    PubMed  CAS  Google Scholar 

  93. Silva, I. D. C. G., Salicioni, A. M., Russo, I. H., Higgy, N. A., Gebrim, L. H., and Russo, J. (1997). Cancer Res. 57, 378–381.

    PubMed  CAS  Google Scholar 

  94. Foekens, J. A., Diamandis, E. P., Yu, H., et al. (1999). Br. J. Cancer 79, 888–894.

    Article  PubMed  CAS  Google Scholar 

  95. Gee, J. M., Willsher, P. C., Kenny, F. S., et al. (1999). Int. J. Cancer 84, 54–61.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Daniel R. Ciocca.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ciocca, D.R., Elledge, R. Molecular markers for predicting response to tamoxifen in breast cancer patients. Endocr 13, 1–10 (2000). https://doi.org/10.1385/ENDO:13:1:1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1385/ENDO:13:1:1

Key Words

Navigation